Global Nanobiotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.

According to our (Global Info Research) latest study, the global Nanobiotechnology market size was valued at USD 69170 million in 2022 and is forecast to a readjusted size of USD 103620 million by 2029 with a CAGR of 5.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Nanobiotechnology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Nanobiotechnology market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nanobiotechnology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nanobiotechnology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nanobiotechnology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nanobiotechnology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nanobiotechnology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Teva Pharmaceuticals, Abbott, UCB and Roche, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Nanobiotechnology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Nanomedicine
    Nano Medical Devices
    Nano Diagnosis
    Other

Market segment by Application
    Anticancer
    CNS Product
    Anti-infective
    Other

Market segment by players, this report covers
    Amgen
    Teva Pharmaceuticals
    Abbott
    UCB
    Roche
    Celgene
    Sanofi
    Merck & Co
    Biogen
    Stryker
    Gilead Sciences
    Pfizer
    3M Company
    Johnson & Johnson
    Smith & Nephew
    Leadiant Biosciences
    Kyowa Hakko Kirin
    Shire
    Ipsen
    Endo International

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanobiotechnology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanobiotechnology, with revenue, gross margin and global market share of Nanobiotechnology from 2018 to 2023.
Chapter 3, the Nanobiotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nanobiotechnology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanobiotechnology.
Chapter 13, to describe Nanobiotechnology research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Nanobiotechnology
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Nanobiotechnology by Type
        1.3.1 Overview: Global Nanobiotechnology Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Nanobiotechnology Consumption Value Market Share by Type in 2022
        1.3.3 Nanomedicine
        1.3.4 Nano Medical Devices
        1.3.5 Nano Diagnosis
        1.3.6 Other
    1.4 Global Nanobiotechnology Market by Application
        1.4.1 Overview: Global Nanobiotechnology Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Anticancer
        1.4.3 CNS Product
        1.4.4 Anti-infective
        1.4.5 Other
    1.5 Global Nanobiotechnology Market Size & Forecast
    1.6 Global Nanobiotechnology Market Size and Forecast by Region
        1.6.1 Global Nanobiotechnology Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Nanobiotechnology Market Size by Region, (2018-2029)
        1.6.3 North America Nanobiotechnology Market Size and Prospect (2018-2029)
        1.6.4 Europe Nanobiotechnology Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Nanobiotechnology Market Size and Prospect (2018-2029)
        1.6.6 South America Nanobiotechnology Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Nanobiotechnology Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Nanobiotechnology Product and Solutions
        2.1.4 Amgen Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Teva Pharmaceuticals
        2.2.1 Teva Pharmaceuticals Details
        2.2.2 Teva Pharmaceuticals Major Business
        2.2.3 Teva Pharmaceuticals Nanobiotechnology Product and Solutions
        2.2.4 Teva Pharmaceuticals Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Teva Pharmaceuticals Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott Nanobiotechnology Product and Solutions
        2.3.4 Abbott Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 UCB
        2.4.1 UCB Details
        2.4.2 UCB Major Business
        2.4.3 UCB Nanobiotechnology Product and Solutions
        2.4.4 UCB Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 UCB Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Nanobiotechnology Product and Solutions
        2.5.4 Roche Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 Celgene
        2.6.1 Celgene Details
        2.6.2 Celgene Major Business
        2.6.3 Celgene Nanobiotechnology Product and Solutions
        2.6.4 Celgene Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Celgene Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Nanobiotechnology Product and Solutions
        2.7.4 Sanofi Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 Merck & Co
        2.8.1 Merck & Co Details
        2.8.2 Merck & Co Major Business
        2.8.3 Merck & Co Nanobiotechnology Product and Solutions
        2.8.4 Merck & Co Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Merck & Co Recent Developments and Future Plans
    2.9 Biogen
        2.9.1 Biogen Details
        2.9.2 Biogen Major Business
        2.9.3 Biogen Nanobiotechnology Product and Solutions
        2.9.4 Biogen Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Biogen Recent Developments and Future Plans
    2.10 Stryker
        2.10.1 Stryker Details
        2.10.2 Stryker Major Business
        2.10.3 Stryker Nanobiotechnology Product and Solutions
        2.10.4 Stryker Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Stryker Recent Developments and Future Plans
    2.11 Gilead Sciences
        2.11.1 Gilead Sciences Details
        2.11.2 Gilead Sciences Major Business
        2.11.3 Gilead Sciences Nanobiotechnology Product and Solutions
        2.11.4 Gilead Sciences Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Gilead Sciences Recent Developments and Future Plans
    2.12 Pfizer
        2.12.1 Pfizer Details
        2.12.2 Pfizer Major Business
        2.12.3 Pfizer Nanobiotechnology Product and Solutions
        2.12.4 Pfizer Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Pfizer Recent Developments and Future Plans
    2.13 3M Company
        2.13.1 3M Company Details
        2.13.2 3M Company Major Business
        2.13.3 3M Company Nanobiotechnology Product and Solutions
        2.13.4 3M Company Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 3M Company Recent Developments and Future Plans
    2.14 Johnson & Johnson
        2.14.1 Johnson & Johnson Details
        2.14.2 Johnson & Johnson Major Business
        2.14.3 Johnson & Johnson Nanobiotechnology Product and Solutions
        2.14.4 Johnson & Johnson Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Johnson & Johnson Recent Developments and Future Plans
    2.15 Smith & Nephew
        2.15.1 Smith & Nephew Details
        2.15.2 Smith & Nephew Major Business
        2.15.3 Smith & Nephew Nanobiotechnology Product and Solutions
        2.15.4 Smith & Nephew Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Smith & Nephew Recent Developments and Future Plans
    2.16 Leadiant Biosciences
        2.16.1 Leadiant Biosciences Details
        2.16.2 Leadiant Biosciences Major Business
        2.16.3 Leadiant Biosciences Nanobiotechnology Product and Solutions
        2.16.4 Leadiant Biosciences Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Leadiant Biosciences Recent Developments and Future Plans
    2.17 Kyowa Hakko Kirin
        2.17.1 Kyowa Hakko Kirin Details
        2.17.2 Kyowa Hakko Kirin Major Business
        2.17.3 Kyowa Hakko Kirin Nanobiotechnology Product and Solutions
        2.17.4 Kyowa Hakko Kirin Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Kyowa Hakko Kirin Recent Developments and Future Plans
    2.18 Shire
        2.18.1 Shire Details
        2.18.2 Shire Major Business
        2.18.3 Shire Nanobiotechnology Product and Solutions
        2.18.4 Shire Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Shire Recent Developments and Future Plans
    2.19 Ipsen
        2.19.1 Ipsen Details
        2.19.2 Ipsen Major Business
        2.19.3 Ipsen Nanobiotechnology Product and Solutions
        2.19.4 Ipsen Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Ipsen Recent Developments and Future Plans
    2.20 Endo International
        2.20.1 Endo International Details
        2.20.2 Endo International Major Business
        2.20.3 Endo International Nanobiotechnology Product and Solutions
        2.20.4 Endo International Nanobiotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Endo International Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Nanobiotechnology Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Nanobiotechnology by Company Revenue
        3.2.2 Top 3 Nanobiotechnology Players Market Share in 2022
        3.2.3 Top 6 Nanobiotechnology Players Market Share in 2022
    3.3 Nanobiotechnology Market: Overall Company Footprint Analysis
        3.3.1 Nanobiotechnology Market: Region Footprint
        3.3.2 Nanobiotechnology Market: Company Product Type Footprint
        3.3.3 Nanobiotechnology Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Nanobiotechnology Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Nanobiotechnology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Nanobiotechnology Consumption Value Market Share by Application (2018-2023)
    5.2 Global Nanobiotechnology Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Nanobiotechnology Consumption Value by Type (2018-2029)
    6.2 North America Nanobiotechnology Consumption Value by Application (2018-2029)
    6.3 North America Nanobiotechnology Market Size by Country
        6.3.1 North America Nanobiotechnology Consumption Value by Country (2018-2029)
        6.3.2 United States Nanobiotechnology Market Size and Forecast (2018-2029)
        6.3.3 Canada Nanobiotechnology Market Size and Forecast (2018-2029)
        6.3.4 Mexico Nanobiotechnology Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Nanobiotechnology Consumption Value by Type (2018-2029)
    7.2 Europe Nanobiotechnology Consumption Value by Application (2018-2029)
    7.3 Europe Nanobiotechnology Market Size by Country
        7.3.1 Europe Nanobiotechnology Consumption Value by Country (2018-2029)
        7.3.2 Germany Nanobiotechnology Market Size and Forecast (2018-2029)
        7.3.3 France Nanobiotechnology Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Nanobiotechnology Market Size and Forecast (2018-2029)
        7.3.5 Russia Nanobiotechnology Market Size and Forecast (2018-2029)
        7.3.6 Italy Nanobiotechnology Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Nanobiotechnology Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Nanobiotechnology Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Nanobiotechnology Market Size by Region
        8.3.1 Asia-Pacific Nanobiotechnology Consumption Value by Region (2018-2029)
        8.3.2 China Nanobiotechnology Market Size and Forecast (2018-2029)
        8.3.3 Japan Nanobiotechnology Market Size and Forecast (2018-2029)
        8.3.4 South Korea Nanobiotechnology Market Size and Forecast (2018-2029)
        8.3.5 India Nanobiotechnology Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Nanobiotechnology Market Size and Forecast (2018-2029)
        8.3.7 Australia Nanobiotechnology Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Nanobiotechnology Consumption Value by Type (2018-2029)
    9.2 South America Nanobiotechnology Consumption Value by Application (2018-2029)
    9.3 South America Nanobiotechnology Market Size by Country
        9.3.1 South America Nanobiotechnology Consumption Value by Country (2018-2029)
        9.3.2 Brazil Nanobiotechnology Market Size and Forecast (2018-2029)
        9.3.3 Argentina Nanobiotechnology Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Nanobiotechnology Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Nanobiotechnology Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Nanobiotechnology Market Size by Country
        10.3.1 Middle East & Africa Nanobiotechnology Consumption Value by Country (2018-2029)
        10.3.2 Turkey Nanobiotechnology Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Nanobiotechnology Market Size and Forecast (2018-2029)
        10.3.4 UAE Nanobiotechnology Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Nanobiotechnology Market Drivers
    11.2 Nanobiotechnology Market Restraints
    11.3 Nanobiotechnology Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Nanobiotechnology Industry Chain
    12.2 Nanobiotechnology Upstream Analysis
    12.3 Nanobiotechnology Midstream Analysis
    12.4 Nanobiotechnology Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Nanobiotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Nanobiotechnology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Nanobiotechnology Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Nanobiotechnology Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Nanobiotechnology Product and Solutions
    Table 8. Amgen Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 11. Teva Pharmaceuticals Major Business
    Table 12. Teva Pharmaceuticals Nanobiotechnology Product and Solutions
    Table 13. Teva Pharmaceuticals Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Teva Pharmaceuticals Recent Developments and Future Plans
    Table 15. Abbott Company Information, Head Office, and Major Competitors
    Table 16. Abbott Major Business
    Table 17. Abbott Nanobiotechnology Product and Solutions
    Table 18. Abbott Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Abbott Recent Developments and Future Plans
    Table 20. UCB Company Information, Head Office, and Major Competitors
    Table 21. UCB Major Business
    Table 22. UCB Nanobiotechnology Product and Solutions
    Table 23. UCB Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. UCB Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche Nanobiotechnology Product and Solutions
    Table 28. Roche Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. Celgene Company Information, Head Office, and Major Competitors
    Table 31. Celgene Major Business
    Table 32. Celgene Nanobiotechnology Product and Solutions
    Table 33. Celgene Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Celgene Recent Developments and Future Plans
    Table 35. Sanofi Company Information, Head Office, and Major Competitors
    Table 36. Sanofi Major Business
    Table 37. Sanofi Nanobiotechnology Product and Solutions
    Table 38. Sanofi Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Sanofi Recent Developments and Future Plans
    Table 40. Merck & Co Company Information, Head Office, and Major Competitors
    Table 41. Merck & Co Major Business
    Table 42. Merck & Co Nanobiotechnology Product and Solutions
    Table 43. Merck & Co Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Merck & Co Recent Developments and Future Plans
    Table 45. Biogen Company Information, Head Office, and Major Competitors
    Table 46. Biogen Major Business
    Table 47. Biogen Nanobiotechnology Product and Solutions
    Table 48. Biogen Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Biogen Recent Developments and Future Plans
    Table 50. Stryker Company Information, Head Office, and Major Competitors
    Table 51. Stryker Major Business
    Table 52. Stryker Nanobiotechnology Product and Solutions
    Table 53. Stryker Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Stryker Recent Developments and Future Plans
    Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 56. Gilead Sciences Major Business
    Table 57. Gilead Sciences Nanobiotechnology Product and Solutions
    Table 58. Gilead Sciences Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Gilead Sciences Recent Developments and Future Plans
    Table 60. Pfizer Company Information, Head Office, and Major Competitors
    Table 61. Pfizer Major Business
    Table 62. Pfizer Nanobiotechnology Product and Solutions
    Table 63. Pfizer Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Pfizer Recent Developments and Future Plans
    Table 65. 3M Company Company Information, Head Office, and Major Competitors
    Table 66. 3M Company Major Business
    Table 67. 3M Company Nanobiotechnology Product and Solutions
    Table 68. 3M Company Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. 3M Company Recent Developments and Future Plans
    Table 70. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 71. Johnson & Johnson Major Business
    Table 72. Johnson & Johnson Nanobiotechnology Product and Solutions
    Table 73. Johnson & Johnson Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Johnson & Johnson Recent Developments and Future Plans
    Table 75. Smith & Nephew Company Information, Head Office, and Major Competitors
    Table 76. Smith & Nephew Major Business
    Table 77. Smith & Nephew Nanobiotechnology Product and Solutions
    Table 78. Smith & Nephew Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Smith & Nephew Recent Developments and Future Plans
    Table 80. Leadiant Biosciences Company Information, Head Office, and Major Competitors
    Table 81. Leadiant Biosciences Major Business
    Table 82. Leadiant Biosciences Nanobiotechnology Product and Solutions
    Table 83. Leadiant Biosciences Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Leadiant Biosciences Recent Developments and Future Plans
    Table 85. Kyowa Hakko Kirin Company Information, Head Office, and Major Competitors
    Table 86. Kyowa Hakko Kirin Major Business
    Table 87. Kyowa Hakko Kirin Nanobiotechnology Product and Solutions
    Table 88. Kyowa Hakko Kirin Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Kyowa Hakko Kirin Recent Developments and Future Plans
    Table 90. Shire Company Information, Head Office, and Major Competitors
    Table 91. Shire Major Business
    Table 92. Shire Nanobiotechnology Product and Solutions
    Table 93. Shire Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Shire Recent Developments and Future Plans
    Table 95. Ipsen Company Information, Head Office, and Major Competitors
    Table 96. Ipsen Major Business
    Table 97. Ipsen Nanobiotechnology Product and Solutions
    Table 98. Ipsen Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Ipsen Recent Developments and Future Plans
    Table 100. Endo International Company Information, Head Office, and Major Competitors
    Table 101. Endo International Major Business
    Table 102. Endo International Nanobiotechnology Product and Solutions
    Table 103. Endo International Nanobiotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. Endo International Recent Developments and Future Plans
    Table 105. Global Nanobiotechnology Revenue (USD Million) by Players (2018-2023)
    Table 106. Global Nanobiotechnology Revenue Share by Players (2018-2023)
    Table 107. Breakdown of Nanobiotechnology by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 108. Market Position of Players in Nanobiotechnology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 109. Head Office of Key Nanobiotechnology Players
    Table 110. Nanobiotechnology Market: Company Product Type Footprint
    Table 111. Nanobiotechnology Market: Company Product Application Footprint
    Table 112. Nanobiotechnology New Market Entrants and Barriers to Market Entry
    Table 113. Nanobiotechnology Mergers, Acquisition, Agreements, and Collaborations
    Table 114. Global Nanobiotechnology Consumption Value (USD Million) by Type (2018-2023)
    Table 115. Global Nanobiotechnology Consumption Value Share by Type (2018-2023)
    Table 116. Global Nanobiotechnology Consumption Value Forecast by Type (2024-2029)
    Table 117. Global Nanobiotechnology Consumption Value by Application (2018-2023)
    Table 118. Global Nanobiotechnology Consumption Value Forecast by Application (2024-2029)
    Table 119. North America Nanobiotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 120. North America Nanobiotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 121. North America Nanobiotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 122. North America Nanobiotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 123. North America Nanobiotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 124. North America Nanobiotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 125. Europe Nanobiotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 126. Europe Nanobiotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 127. Europe Nanobiotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 128. Europe Nanobiotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 129. Europe Nanobiotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Nanobiotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Nanobiotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 132. Asia-Pacific Nanobiotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 133. Asia-Pacific Nanobiotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 134. Asia-Pacific Nanobiotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 135. Asia-Pacific Nanobiotechnology Consumption Value by Region (2018-2023) & (USD Million)
    Table 136. Asia-Pacific Nanobiotechnology Consumption Value by Region (2024-2029) & (USD Million)
    Table 137. South America Nanobiotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 138. South America Nanobiotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 139. South America Nanobiotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 140. South America Nanobiotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 141. South America Nanobiotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 142. South America Nanobiotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 143. Middle East & Africa Nanobiotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Nanobiotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 145. Middle East & Africa Nanobiotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 146. Middle East & Africa Nanobiotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Nanobiotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 148. Middle East & Africa Nanobiotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 149. Nanobiotechnology Raw Material
    Table 150. Key Suppliers of Nanobiotechnology Raw Materials
List of Figures
    Figure 1. Nanobiotechnology Picture
    Figure 2. Global Nanobiotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Nanobiotechnology Consumption Value Market Share by Type in 2022
    Figure 4. Nanomedicine
    Figure 5. Nano Medical Devices
    Figure 6. Nano Diagnosis
    Figure 7. Other
    Figure 8. Global Nanobiotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Nanobiotechnology Consumption Value Market Share by Application in 2022
    Figure 10. Anticancer Picture
    Figure 11. CNS Product Picture
    Figure 12. Anti-infective Picture
    Figure 13. Other Picture
    Figure 14. Global Nanobiotechnology Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Nanobiotechnology Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Nanobiotechnology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Nanobiotechnology Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Nanobiotechnology Consumption Value Market Share by Region in 2022
    Figure 19. North America Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Nanobiotechnology Revenue Share by Players in 2022
    Figure 25. Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Nanobiotechnology Market Share in 2022
    Figure 27. Global Top 6 Players Nanobiotechnology Market Share in 2022
    Figure 28. Global Nanobiotechnology Consumption Value Share by Type (2018-2023)
    Figure 29. Global Nanobiotechnology Market Share Forecast by Type (2024-2029)
    Figure 30. Global Nanobiotechnology Consumption Value Share by Application (2018-2023)
    Figure 31. Global Nanobiotechnology Market Share Forecast by Application (2024-2029)
    Figure 32. North America Nanobiotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Nanobiotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Nanobiotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Nanobiotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Nanobiotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Nanobiotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Nanobiotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Nanobiotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Nanobiotechnology Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Nanobiotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Nanobiotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Nanobiotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Nanobiotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Nanobiotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Nanobiotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Nanobiotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 66. Nanobiotechnology Market Drivers
    Figure 67. Nanobiotechnology Market Restraints
    Figure 68. Nanobiotechnology Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Nanobiotechnology in 2022
    Figure 71. Manufacturing Process Analysis of Nanobiotechnology
    Figure 72. Nanobiotechnology Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International